Deng S, Cong B, Edgoose M, De Wit F, Nair H, Li Y. Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: an updated systematic review and meta-analysis. Int J Infect Dis. 2024;146: 107125. https://doi.org/10.1016/j.ijid.2024.107125.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024; 24(9):974–1002. https://doi.org/10.1016/S1473-3099(24)00176-2.
Waddell CJ, Saldana CS, Schoonveld MM, Meehan AA, Lin CK, Butler JC, Mosites E. Infectious diseases among people experiencing homelessness: a systematic review of the literature in the United States and Canada, 2003–2022. Public Health Rep. 2024;139(5):532–48. https://doi.org/10.1177/00333549241228525.
Heemskerk S, van Heuvel L, Asey T, Bangert M, Kramer R, Paget J, van Summeren J. Disease burden of RSV infections and bronchiolitis in young children (< 5 years) in primary care and emergency departments: a systematic literature review. Influenza Other Respir Viruses. 2024;18(8): e13344. https://doi.org/10.1111/irv.13344.
Article PubMed PubMed Central Google Scholar
Sebina I, Phipps S. The contribution of neutrophils to the pathogenesis of RSV bronchiolitis. Viruses. 2020;12(8):808. https://doi.org/10.3390/v12080808.
Article CAS PubMed PubMed Central Google Scholar
Kalinowski A, Ueki I, Min-Oo G, Ballon-Landa E, Knoff D, Galen B, Lanier LL, Nadel JA, Koff JL. EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production. Am J Physiol Lung Cell Mol Physiol. 2014;307(2):L186–96. https://doi.org/10.1152/ajplung.00368.2013.
Article CAS PubMed PubMed Central Google Scholar
Li J, Li M, Wang X, Sun M, Ma C, Liang W, Gao X, Wei L. Long noncoding RNA NRAV promotes respiratory syncytial virus replication by targeting the microRNA miR-509-3p/Rab5c axis to regulate vesicle transportation. J Virol. 2020;94(10):e00113-e120. https://doi.org/10.1128/JVI.00113-20.
Article CAS PubMed PubMed Central Google Scholar
Drajac C, Laubreton D, Riffault S, Descamps D. pulmonary susceptibility of neonates to respiratory syncytial virus infection: a problem of innate immunity? J Immunol Res. 2017;2017:8734504. https://doi.org/10.1155/2017/8734504.
Article CAS PubMed PubMed Central Google Scholar
Danishyar A, Ashurst JV. Acute otitis media. [Updated 2020 Aug 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470332/
Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases. Front Neurosci. 2020;14:716. https://doi.org/10.3389/fnins.2020.00716.
Article PubMed PubMed Central Google Scholar
Farrag MA, Almajhdi FN. Human respiratory syncytial virus: role of innate immunity in clearance and disease progression. Viral Immunol. 2016;29(1):11–26. https://doi.org/10.1089/vim.2015.0098.
Article CAS PubMed Google Scholar
Gern JE. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol. 2009;1:73–8. https://doi.org/10.1097/ACI.0b013e32831f8f1b.
Busse DC, Habgood-Coote D, Clare S, Brandt C, Bassano I, Kaforou M, Herberg J, Levin M, Eléouët JF, Kellam P, Tregoning JS. Interferon-induced protein 44 and interferon-induced protein 44-like restrict replication of respiratory syncytial virus. J Virol. 2020;94(18):e00297-e320. https://doi.org/10.1128/JVI.00297-20.
Article PubMed PubMed Central Google Scholar
Öner D, Drysdale SB, McPherson C, Lin GL, Janet S, Broad J, Pollard AJ, Aerssens J, RESCEU Investigators. Biomarkers for disease severity in children infected with respiratory syncytial virus: a systematic literature review. J Infect Dis. 2020;222(Suppl 7):S648–57. https://doi.org/10.1093/infdis/jiaa208.
Article CAS PubMed Google Scholar
Khatiwada S, Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): possible link and implications. Hum Microb J. 2020;17: 100073. https://doi.org/10.1016/j.humic.2020.100073.
Article PubMed PubMed Central Google Scholar
Harrod KS, Jaramillo RJ, Rosenberger CL, Wang SZ, Berger JA, McDonald JD, Reed MD. Increased susceptibility to RSV infection by exposure to inhaled diesel engine emissions. Am J Respir Cell Mol Biol. 2003;4:451–63. https://doi.org/10.1165/rcmb.2002-0100OC.
Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. 1999;2:298–309. https://doi.org/10.1128/CMR.12.2.298.
Baskerville A. Mechanisms of infection in the respiratory tract. N Z Vet J. 1981;12:235–8. https://doi.org/10.1080/00480169.1981.34852.
Martín-Vicente M, González-Riaño C, Barbas C, Jiménez-Sousa MÁ, Brochado-Kith O, Resino S, Martínez I. Metabolic changes during respiratory syncytial virus infection of epithelial cells. PLoS ONE. 2020;15(3): e0230844. https://doi.org/10.1371/journal.pone.0230844.
Article CAS PubMed PubMed Central Google Scholar
Diaz-Diaz A, Garcia-Maurino C, Jordan-Villegas A, Naples J, Ramilo O, Mejias A. Viral bacterial interactions in children: impact on clinical outcomes. Pediatr Infect Dis J. 2019;38(6S Suppl 1):S14–9. https://doi.org/10.1097/INF.0000000000002319.
Article PubMed PubMed Central Google Scholar
Dubourg G, Edouard S, Raoult D. Relationship between nasopharyngeal microbiota and patient’s susceptibility to viral infection. Expert Rev Anti Infect Ther. 2019;17(6):437–47. https://doi.org/10.1080/14787210.2019.1621168.
Article CAS PubMed Google Scholar
Lukacs NW, Smit J, Lindell D, Schaller M. Respiratory syncytial virus-induced pulmonary disease and exacerbation of allergic asthma. Contrib Microbiol. 2007;14:68–82. https://doi.org/10.1159/000107055.
Salkind AR, Roberts NJ Jr. Recent observations regarding the pathogenesis of recurrent respiratory syncytial virus infections: implications for vaccine development. Vaccine. 1992;10(8):519–23. https://doi.org/10.1016/0264-410x(92)90350-s.
Article CAS PubMed Google Scholar
Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004;6(8):767–72. https://doi.org/10.1016/j.micinf.2004.03.010.
Piedimonte G, Perez MK. Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs? Curr Opin Pharmacol. 2014;16:82–8. https://doi.org/10.1016/j.coph.2014.03.008.
Article CAS PubMed Google Scholar
Piedimonte G. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection. Pediatr Infect Dis J. 2003;22(2 Suppl):S66-74. https://doi.org/10.1097/01.inf.0000053888.67311.1d. (discussion S74–5).
Garofalo RP, Kolli D, Casola A. Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(2):186–217. https://doi.org/10.1089/ars.2011.4307.
Article CAS PubMed PubMed Central Google Scholar
Wang XH, Shu J, Jiang CM, Zhuang LL, Yang WX, Zhang HW, Wang LL, Li L, Chen XQ, Jin R, Zhou GP. Mechanisms and roles by which IRF-3 mediates the regulation of ORMDL3 transcription in respiratory syncytial virus infection. Int J Biochem Cell Biol. 2017;87:8–17. https://doi.org/10.1016/j.biocel.2017.03.007.
Article CAS PubMed Google Scholar
Openshaw PJ. Potential mechanisms causing delayed effects of respiratory syncytial virus infection. Am J Respir Crit Care Med. 2001;163(3 Pt 2):S10–3. https://doi.org/10.1164/ajrccm.163.supplement_1.2011111.
Comments (0)